Abstract
A method of attenuating cocaine-seeking behavior in a subject. The method includes administering a physiologically effective amount of glial cell-derived neurotrophic factor (GDNF) into a selected region of the brain. Preferaby a controlled release mechanism is employed. GDNF as a pharmaceutical composition, preferably supplied as an article of manufacture including instructions for use in attenuating cocaine-seeking behavior, is also disclosed. The claimed invention includes, but is not limited to, a physiologically effective dose in the range of one to twenty micrograms/day.
Original language | American English |
---|---|
Patent number | US20050020499 A1 |
State | Published - 2004 |